MSB 1.03% 98.0¢ mesoblast limited

teva q3 earnings call (q&a session)., page-4

  1. 5,344 Posts.
    lightbulb Created with Sketch. 955
    Hi 4s, Great input no doubt you are a very astute with MSB .. You suggested to look at at Maxim Report on 28th January 2013 which hosted a Cadiology Dinner with three world-class Cardiologists and key opinion leaders: Emerson Perin MD, Kenneth M Borrow MD and Warren Sherman MD.
    The "experts found the high-dose data absolutely compelling when considering all the parameters of cadiac health and cardiac MACE".... And I will do that . thanks ..

    (Regarding the 125 patient interim analysis -you said your views are quite the opposite and shows confidence by TEVA with the MPC technology, I agree ...
    My suggestion is when that interim analysis comes in early 2014 it will have an FDA" fast track"
    a life saving "push it thu " to save lives this will be the major one for MSB not to forget D2 and a host of stuff coming thu some slip your mind there are so many ,then you find another.. ....Cheers Vin
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
98.0¢
Change
0.010(1.03%)
Mkt cap ! $1.118B
Open High Low Value Volume
96.0¢ 99.0¢ 95.5¢ $5.286M 5.409M

Buyers (Bids)

No. Vol. Price($)
3 91218 98.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.0¢ 63577 4
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.